Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets.
Ratings
3 / 5
2 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Prahlad R. Singh$12.3B
Market Cap • 18/04/20241947
(há 77 anos)
1983
(41 years ago)
NYSE
ListagemS&P500 Participant
Index Composite • 2024
Waltham
Sede • MassachusettsValuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
RVTYSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.